http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1305793-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7ad58d3c0b071069a8ee0cb8c8ba2e8 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-04 |
filingDate | 1970-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e3931deb766b9fd98c04d0b8ffe34ac |
publicationDate | 1973-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | GB-1305793-A |
abstract | 1305793 A process for production of N-alkyl- 1,4-dihydropyridines BAYER AG 21 April 1970 [10 May 1969 18 Oct 1969 4 March 1970] 19027/70 Heading C2C A process for the production of compounds of the general Formula I where R is a saturated or unsaturated aliphatic radical optionally fused to form a ring and further optionally substituted and/or interrupted by a hetero atom; or an optionally substituted araliphatic radical; R<SP>1</SP> is hydrogen or a C 1 to C 4 alkyl or an optionally substituted aryl or a heterocyclic radical; R<SP>11</SP> is a C 1 to C 6 saturated or unsaturated aliphatic radical optionally in the form of a ring and optionally interrupted by a hetero atom; and X is a saturated or unsaturated aliphatic or homocyclic radical or a heterocyclic radical or an optionally substituted aryl, aralkyl or aralkylene radical comprises reacting an aldehyde X.CHO and a #-keto carboxylic acid ester R<SP>1</SP>COCH 2 COOR<SP>11</SP> with a salt of an alkylamine RNH 2 in the presence of an acid acceptor. Pharmaceutical compositions of I with the usual excipients show a long-lasting dilating effect on coronary vessels. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2511247-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0071819-A1 |
priorityDate | 1969-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Predicate | Subject |
---|---|
isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392901 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783 |
Total number of triples: 21.